Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorLing, Clare L.
dc.contributor.authorOravcova, Katarina
dc.contributor.authorBeattie, Thomas Ferris
dc.contributor.authorCreer, Dean D.
dc.contributor.authorDilworth, Paul
dc.contributor.authorFulton, Naomi L.
dc.contributor.authorHardie, Alison
dc.contributor.authorMunro, Michelle
dc.contributor.authorPond, Marcus
dc.contributor.authorTempleton, Kate
dc.contributor.authorWebster, David
dc.contributor.authorWorkman, Sarita
dc.contributor.authorMcHugh, Timothy D.
dc.contributor.authorGillespie, Stephen Henry
dc.date.accessioned2014-08-25T13:31:00Z
dc.date.available2014-08-25T13:31:00Z
dc.date.issued2014-04
dc.identifier138259004
dc.identifiera35deae7-8fb9-494c-bd0e-b3131d01ede3
dc.identifier84897145728
dc.identifier000332832300024
dc.identifier.citationLing , C L , Oravcova , K , Beattie , T F , Creer , D D , Dilworth , P , Fulton , N L , Hardie , A , Munro , M , Pond , M , Templeton , K , Webster , D , Workman , S , McHugh , T D & Gillespie , S H 2014 , ' Tools for detection of Mycoplasma amphoriforme : a primary respiratory pathogen? ' , Journal of Clinical Microbiology , vol. 52 , no. 4 , pp. 1177-1181 . https://doi.org/10.1128/JCM.03049-13en
dc.identifier.issn0095-1137
dc.identifier.otherORCID: /0000-0001-6537-7712/work/39477881
dc.identifier.urihttps://hdl.handle.net/10023/5222
dc.descriptionThis work was supported by a Peter Samuel Royal Free Fund grant, the Primary Immunodeficiency Association, the Special Trustees of the Royal Free London NHS Foundation Trust, Hampstead, and the University of St. Andrews Medical School.en
dc.description.abstractMycoplasma amphoriforme is a recently described organism isolated from the respiratory tracts of patients with immunodeficiency and evidence of chronic infection. Novel assays for the molecular detection of the organism by real-time quantitative PCRs (qPCRs) targeting the uracil DNA glycosylase gene (udg) or the 23S rRNA gene are described here. The analytical sensitivities are similar to the existing conventional M. amphoriforme 16S rRNA gene PCR, with the advantage of being species specific, rapid, and quantitative. By using these techniques, we demonstrate the presence of this organism in 17 (19.3%) primary antibody-deficient (PAD) patients, 4 (5%) adults with lower respiratory tract infection, 1 (2.6%) sputum sample from a patient attending a chest clinic, and 23 (0.21%) samples submitted for viral diagnosis of respiratory infection, but not in normal adult control subjects. These data show the presence of this microorganism in respiratory patients and suggest that M. amphoriforme may infect both immunocompetent and immunocompromised people. Further studies to characterize this organism are required, and this report provides the tools that may be used by other research groups to investigate its pathogenic potential.
dc.format.extent5
dc.format.extent203969
dc.language.isoeng
dc.relation.ispartofJournal of Clinical Microbiologyen
dc.subjectMycoplasmaen
dc.subjectPathogen discoveren
dc.subjectLower respiratory tract infectionen
dc.subjectQR Microbiologyen
dc.subject.lccQRen
dc.titleTools for detection of Mycoplasma amphoriforme : a primary respiratory pathogen?en
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Gillespie Groupen
dc.contributor.institutionUniversity of St Andrews. Global Health Implementation Groupen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews. Infection Groupen
dc.identifier.doi10.1128/JCM.03049-13
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record